Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BridGene Says "Galapagos Will Pay Up To $27M In Upfront And Preclinical Research Milestone Payments, More Than $700M In Clinical And Commercial Milestones; Eligible To Receive Tiered Royalties On Net Sales Of Each Product Resulting From The Collaboration"

Author: Benzinga Newsdesk | January 03, 2024 05:01pm

Posted In: GLPG

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist